BNP Paribas Issuance (P1KOD5) 시세

https://www.investing.com/news/insider-trading-news/oktas-chief-legal-officer-sells-over-13-million-in-stock-93CH-3942830

Yep, the insiders keep selling at Okta!! Device authentication with the TPM (which is backed by the Trusted Computing Group - 100+ companies) and Wave Systems Cor

Quail Hollow Capital's Convertible Note?

https://www.globenewswire.com/news-release/2025/03/18/3044986/0/en/HUMBL-Inc-Secures-500-000-in-Strategic-Investment-From-Quail-Hollow-Capital-LLC.html

That was the news?

Cool.

Market didn't seem t

Then there was the sim card ejector experience....

Your answer is the hair on ones head?  What does that have to do with EO polymers??.
X  punk, grow up.

Not the brightest bulb in the ceiling....the one and same that was warning folks away from TSNP/HMBL, our sister stock just before it went ballistic LMFAO

Looks like Hsu's calendar is filled in with "Trial Day 5" for the 00993 case - on Monday.

https://www.cacd.uscourts.gov/sites/default/files/documents/WLH/MC/e3da1cfb-d4dd-4256-92dd-4cd721b98cc0.pdf

Why beat a dead horse?

Zero (0) chance 7 figures is true. 🤣

The PeaNutjobs wish or dream the PSPA would come back, instead we get the 7 11 effect. Ps thought they would get Par and convert to commons at 10c, then a fantasy dream or wish would somehow make commons go up as sucker investors bought into their get rich scam.

Still under a $25 million total market cap at .15

BEST SELLERS RANK (BSR) IS 258 72 Estimated Sold on Amazon Since JAN 1 - 1ST Quarter 2025
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec

Unbelievable the lengths these Generics go to. Trying to persuade the SCOTUS that they have the rights to infringe? Really?

From .02 to .15+ please

Nibbling on the bid of wddd might be a good idea
May look like a fool
Hopefully some news comes soon
Worth a shot

Michael LaBarre Biography and Net Worth
Chief Technical Officer of Halozyme Therapeutics
Dr. LaBarre brings to Halozyme more than 25 years of experience across all aspects of biopharmaceutical research and drug development, including strong expertise in chemistry, manufacturing, and co

I guess it is too much to ask of the stock gods that our sp rise over $1 before RS (RS is set in stone and I guess would happen anyway) but it is possibly (and hopefully) the stock is higher than today on April 11. Maybe we open at $15 that day?

Yup…Still up there!

DCVax® – L Phase III for GBM Brain Cancer
Status: Enrollment Completed in 2015
For a complete listing of clinical trial sites, details, and contact information please Click Here.

Our lead product is DCVax-L for Glioblastoma multiforme (

When the share price tanks and there is still no gold revenue and still no real evidence of PGMs or economic REE......maybe, just maybe, investors will hold Sean Rae and Sunny accountable for all the lies.

Then again, maybe not.... investors will blame Shorty, corrupt MMs, etc. SMH.

AGH on Stocktwits no news at the moment

Haha ugh I know.

Enjoy.

Perhaps something useful about the filing... implies something about decision timing? It's bidding higher than the close at $0.47 in the after hours... 19k volume.

Hey, welcome aboard new bag holders! Surely here to find out what disaster you bought after chasing the press release. Due diligence is supposed to come before you buy. 😏 The old bag holders probably couldn't believe their lucky exit today. If you held you are hopeless unfortunately. ὠ

DAR, I look forward to reading our response. I don't think the court will take this. They are busy with issues that actually threaten democracy. I assume Hatch Waxman won't be a priority.
Sleven,

continuing progress reports on ongoing P2 trial will send shares flying soon. enrollment is already passing the halfway mark.

They can't generate any type of revenue so this is the only way they can keep the lights on and keep the paychecks flowing by constantly selling shares and dilution.

Great business strategy the last 15 years. 👏
New CEO but same old same old.
WASH RINSE REPEAT